AXSM News and Press, Axsome Therapeutics Inc. From 05/05/23

2023-05-05 12:17:49 ET Axsome Therapeutics ( NASDAQ: AXSM ) is scheduled to announce Q1 earnings results on Monday, May 8th, before market open. The consensus EPS Estimate is -$1.13 (-9.7% Y/Y) and the consensus Revenue Estimate is $25.48M Over the last 1 year, AXSM ...

2023-05-05 11:40:34 ET Major earning expected before the bell on Monday include: BioNTech ( BNTX ) DISH Network ( DISH ) KKR & Co. ( KKR ) Tyson Foods ( TSN ) Viatris ( VTRS ) For further details see: Notable earnings before Monday's open

NEW YORK, May 03, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that Herriot Tabuteau, MD, Axsome’s Chief Executive Offic...

2023-05-02 14:08:58 ET Summary Axsome Therapeutics, Inc. has a lot of good things happening. Axsome Therapeutics has the potential to become a large CNS-focused biopharma. Cash is the only short-term worry for Axsome Therapeutics, Inc., but I wouldn't worry too much if the tri...

NEW YORK, May 01, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, is joining Mental Health America (MHA) and the State of New York to raise awaren...

2023-04-28 06:26:31 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The biotech sector is up 4.76% so far in 2023. This continues the nice run that biotech stocks had in 2022. The gains in biotech were in stark contrast to the broader market. All the majo...

2023-04-25 06:00:39 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors have shown keen interest in biotech after Johnson & Johnson’s (NYSE: JNJ ) impressive earnings beat that topped Wall Street’s expectations. The e...

2023-04-25 05:30:00 ET Some stocks soar overnight. But in most cases, you'll have a better chance of winning in the stock market if you buy and hold on for at least five years. This generally allows you to benefit from a company's development and earnings growth -- or in the case of a young...

2023-04-22 06:18:00 ET In some industries, quarterly earnings updates provide the main news that holds the potential to drive stocks higher. It's a different story in the biopharmaceutical world. Clinical updates and regulatory decisions can happen throughout the year. Three Motley Fool...

NEW YORK, April 21, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that it will be presenting five abstracts at the upcoming 2023...